Thomas Kammertöns
Impact in
-
- Virus-based gene therapy research
-
- Cancer Research and Treatments
Papers in
- Oncology 5
- CAR-T cell therapy research 3
- Lymphatic System and Diseases 1
-
- Immune Cell Function and Interaction 3
- Co-authors
- Thomas Blankenstein (3 shared papers)Wolfgang Uckert (3 shared papers)Karin Haack (1 shared paper)Johannes Gebert (1 shared paper)Zhihai Qin (1 shared paper)Dolores J. Schendel (1 shared paper)Uta E. Höpken (1 shared paper)Lars Bullinger (2 shared papers)
- Journals
- Human Gene Therapy (1 paper)Blood (1 paper)International Journal of Cancer (1 paper)Cytotherapy (1 paper)Cancer Research (1 paper)
- Partner nations
- GermanyUnited StatesCanada
In The Last Decade
Thomas Kammertöns
6 papers receiving 107 citations
Peers
Comparison fields: 5 of 25
- Genetics 67
- Biotechnology 20
- Oncology 39
- Immunology 29
- Molecular Biology 61
Countries citing papers authored by Thomas Kammertöns
This map shows the geographic impact of Thomas Kammertöns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kammertöns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kammertöns more than expected).
Fields of papers citing papers by Thomas Kammertöns
This network shows the impact of papers produced by Thomas Kammertöns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kammertöns. The network helps show where Thomas Kammertöns may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Kammertöns, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 77 | |
| 2 | 2020 | 13 | |
| 3 | 2024 | 9 | |
| 4 | 2022 | 5 | |
| 5 | 2004 | 3 | |
| 6 | 2014 | 1 |
About Thomas Kammertöns
Thomas Kammertöns is a scholar working on Oncology, Immunology, Molecular Biology, Genetics and Pathology and Forensic Medicine, having authored 6 papers that have together received 108 indexed citations. Recurring topics across this work include CAR-T cell therapy research (3 papers), Immune Cell Function and Interaction (3 papers), Virus-based gene therapy research (2 papers), Lymphoma Diagnosis and Treatment (1 paper), Lymphatic System and Diseases (1 paper), Cytomegalovirus and herpesvirus research (1 paper), Hematopoietic Stem Cell Transplantation (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Genetics (67 citations), Biotechnology (20 citations), Oncology (39 citations), Immunology (29 citations) and Molecular Biology (61 citations). Thomas Kammertöns has collaborated with scholars based in Germany, United States and Canada. Frequent co-authors include Thomas Blankenstein, Wolfgang Uckert, Karin Haack, Johannes Gebert, Zhihai Qin, Dolores J. Schendel, Uta E. Höpken, Lars Bullinger, Lutz Menzel and Ioannis Anagnostopoulos. Their work appears in journals such as Human Gene Therapy, Blood, International Journal of Cancer, Cytotherapy and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.